Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| LPGDorian Lpg Ltd. | $2.33B | 7.2× | $481.51M | +36.3% | $193.67M | $342.14M | $646.24M | Fair valued |
| LULufax Holding Ltd | $2.33B | — | CN¥8.16B | -46.7% | -CN¥3.6B | CN¥11.8B | CN¥51.42B | Undervalued |
| CCChemours Co | $2.33B | — | $5.81B | +0.4% | -$386M | $671M | $4.16B | Fair valued |
| XIFRXPLR Infrastructure, LP | $2.33B | 18.1× | $1.19B | -3.4% | -$28M | $943M | $6.33B | Fair valued |
| CENTCentral Garden & Pet Co | $2.33B | 15.6× | $3.13B | -2.2% | $162.84M | $996.71M | $1.41B | Fair valued |
| SRPTSarepta Therapeutics, Inc. | $2.33B | — | $1.86B | +4.3% | -$713.41M | $571.15M | $1.05B | Fair valued |
| VVXV2X, Inc. | $2.34B | 25.7× | $4.48B | +3.7% | $77.88M | $214.31M | $1.06B | Fair valued |
| HCIHCI Group, Inc. | $2.34B | 8.1× | $900.95M | +20.1% | $299.01M | $872.34M | $31.47M | Fair valued |
| EFSCEnterprise Financial Services Corp | $2.35B | 12.9× | $739.86M | +16.0% | $201.37M | $552.06M | $27.14M | Fair valued |
| BHVNBiohaven Ltd. | $2.35B | — | — | — | — | $238.03M | $37.56M | Fair valued |
| PTONPeloton Interactive, Inc. | $2.35B | 48.7× | $2.45B | -1.8% | $63.2M | $1.21B | $765.1M | Undervalued |
| LASRNlight, Inc. | $2.35B | — | $261.33M | +31.6% | -$23.47M | $295.76M | $14.84M | Overvalued |
| OCULOcular Therapeutix, Inc | $2.35B | — | $51.95M | -18.5% | -$265.94M | $598.64M | $6.59M | Overvalued |
| GSHDGoosehead Insurance, Inc. | $2.36B | 48.3× | $365.3M | — | $27.83M | $23.66M | $372.84M | Overvalued |
| COHUCohu Inc | $2.36B | — | $452.96M | +12.7% | -$74.27M | $219.61M | $331.25M | Overvalued |
| ANDEAndersons, Inc. | $2.36B | 13.4× | $1.53B | +9.1% | $95.71M | $66.55M | $900.77M | Fair valued |
| PBIPitney Bowes Inc | $2.36B | 14.0× | $1.89B | -6.6% | $144.7M | $266.83M | $2.16B | Fair valued |
| HLIOHelios Technologies, Inc. | $2.37B | 33.4× | $839M | +4.1% | $48.4M | $68M | $245.2M | Fair valued |
| PLUSEplus Inc | $2.37B | 18.9× | $2.44B | +23.3% | $132.64M | $448.85M | $16.29M | Undervalued |
| NUVBNuvation Bio Inc. | $2.37B | — | $62.9M | +699.0% | -$204.63M | $258.6M | $252.14M | Fair valued |